Yunkang Group Limited (HKG:2325)

Market Cap	468.28M -84.7%
Revenue (ttm)	706.95M -18.8%
Net Income	-789.94M
EPS	-1.34
Shares Out	585.34M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	102,000
Average Volume	2,509,200
Open	0.7700
Previous Close	0.7700
Day's Range	0.7400 - 0.8100
52-Week Range	0.6500 - 5.0000
Beta	-0.77
RSI	51.25
Earnings Date	Mar 27, 2026

About Yunkang Group

Yunkang Group Limited operates as a medical operation service provider in the People's Republic of China. The company offers diagnostic testing services for medical institution alliances, including setting up or upgrading diagnostic centers, the establishment of standard operating procedures for diagnostic testing, diagnostic consultation and staff training, procurement of equipment, smart internet of things, and logistics assistance. It also provides diagnostic outsourcing services comprising pathology tests; infectious disease diagnostic test...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2008
• Employees: 1,146
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2325

Financial Performance

In 2024, Yunkang Group's revenue was 711.88 million, a decrease of -20.15% compared to the previous year's 891.50 million. Losses were -791.68 million, 674.2% more than in 2023.

Financial numbers in CNY